Safety-Related Labeling Changes
New onset immune disorders (e.g., psoriasis, rheumatoid arthritis, inflammatory bowel disease) and Rheumatoid arthritis
Trade Name
Xifi
Updated Section
4.8 Undesirable effects
Month
Feb,2026